NDTVCenter·
Symbiotec Pharmalab IPO GMP In Focus As Issue Opens For Subscription
Symbiotec Pharmalab IPO opened on Aug. 24 with a Rs 1,757 crore issue. GMP signals a 41.40% listing gain at the upper price band.
Read at NDTV →
Business · 1 sources covering this
Symbiotec Pharmalab IPO GMP In Focus As Issue Opens For Subscription
Symbiotec Pharmalab IPO opened on Aug. 24 with a Rs 1,757 crore issue. GMP signals a 41.40% listing gain at the upper price band.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/8b87a9134629aa05412c0378a1179358cc4ad0fe" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Symbiotec Pharmalab IPO GMP In Focus As Issue Opens For Subscription"></iframe>
